Dechun Liu

Dechun Liu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Anti-Cancer Drugs
Verified
Journal Article
Closed access
MDMiao Deng
Miao Deng
JWJianguang Wang
Jianguang Wang
YCYanbin Chen
Yanbin Chen
LZLike Zhang
Like Zhang
DLDechun Liu
Dechun Liu
To investigate the apoptotic mechanism of triple-negative breast cancer (TNBC) cells induced by gefitinib and PI3K inhibitor SF1126. MDA-MB-231, MDA-MB-436, and MCF-7 cells were incubated with 0.1 μmol/l gefitinib, 1 μmol/l gefitinib, 10 μmol/l gefitinib, 1 μmol/l SF1126, 0.1 μmol/l gefitinib+1 μmol/l SF1126, 1 μmol/l gefitinib+1 μmol/l SF1126, and 10 μmol/l gefitinib+1 μmol/l SF1126. Then, cell viability and survival were determined using an 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) assay and Hoechst staining. The apoptosis-related factors and phosphoinositide-3-kinase/protein kinase B, the mammalian target of rapamycin (PI3K/AKT-mTOR) signaling pathway-related factors were detected by western blot. For TNBC cells, cell viability or survival was not significantly inhibited by gefitinib or SF1126 alone; however, marked cell apoptosis was noted in the gefitinib and SF1126 combination groups, and this effect was dose dependent. Also, the expressions of apoptosis markers, such as cleaved caspase-3, Bcl-2/Bax, were altered by the gefitinib and SF1126 combination. Moreover, phosphorylated AKT (p-AKT) and 70 kDa ribosomal protein S6-kinase (p-p70S6K) were also inhibited by the gefitinib and SF1126 combination, which may be responsible for the apoptosis. Gefitinib combined with SF1126 could induce cell apoptosis in TNBC cells and this effect was mediated through the EGFR-PI3K-AKT-mTOR-p70S6K pathway. Our studies have set the stage for future clinical trials of TNBC therapy by the combination of gefitinib and SF1126.

14 June 2016 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
MDMiao Deng
Miao Deng
JWJianguang Wang
Jianguang Wang
YCYanbin Chen
Yanbin Chen
LZLike Zhang
Like Zhang
GXGangqiang Xie
Gangqiang Xie
DLDechun Liu
Dechun Liu
Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which is hypothesized to regulate cell cycle progression in tumor cells. However, whether CDKN3 is a potential therapeutic target for breast cancer remains to be elucidated. The present in vitro study aimed to investigate the potential roles of CDKN3 in breast cancer. Breast cancer cell lines were used to detect CDKN3 expression, and CDKN3 expression was silenced to investigate its role in cell apoptosis, cell cycle arrest and migration. The underlying mechanisms were screened by detecting proliferating cell nuclear antigen (PCNA), Ras homolog gene family, member A (RhoA), vimentin, B‑cell lymphoma 2 (Bcl‑2) and Bcl‑2‑associated X protein (Bax) expression. CDKN3 was highly expressed in MCF‑7 and BT474 cell lines. The silencing of CDKN3 in MCF‑7 and BT474 cell lines promoted cell apoptosis, induced G1 phase cell cycle arrest and inhibited cell migration. The expression levels of PCNA, RhoA, vimentin and Bcl‑2 were downregulated following CDKN3 silencing. Conversely, Bax expression was increased, as compared with the vehicle control. These results suggest that CDKN3 acts as an oncogene during breast cancer progression. The in vitro silencing of CDKN3 promoted apoptosis, induced G1 phase cell cycle arrest and inhibited cell migration. Possible mechanisms are associated with the regulation of PCNA, Bcl‑2, vimentin, RhoA and Bax expression. CDKN3 may therefore be considered a potential target for the treatment of breast cancer.

27 February 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZDZhe Du
Zhe Du
PZPujing Zhang
Pujing Zhang
XHXiaodong Huang
Xiaodong Huang
ZHZhigang Hu
Zhigang Hu
GYGege Yang
Gege Yang
DLDechun Liu
Dechun Liu
The color variations present in histopathological images pose a significant challenge to computational pathology and, consequently, negatively affect the performance of certain pathological image analysis methods, especially those based on deep learning techniques. To date, several methods have been proposed to mitigate this issue. However, these methods either produce images with low texture retention, perform poorly when trained with small datasets, or have low generalization capabilities. In this paper, we propose a Deep Supervised Two-stage Generative Adversarial Network known as DSTGAN for stain-normalization. Specifically, we introduce deep supervision to generative adversarial networks in an innovative way to enhance the learning capacity of the model, benefiting from different model regularization methods. To make fuller use of source domain images for training the model, we drew upon semi-supervised concepts to design a novel two-stage staining strategy. Additionally, we construct a generator that can capture long-distance semantic relationships, enabling the model to retain more abundant texture information in the generated images. In the evaluation of the quality of generated images, we have achieved state-of-the-art performance on TUPAC-2016, MITOS-ATYPIA-14, ICIAR-BACH-2018 and MICCAI-16-GlaS datasets, improving the precision of classification and segmentation by 5.2% and 4.2%, respectively. Not only has our model significantly improved the quality of the stained images compared to existing stain normalization methods, but it also has a positive impact on the execution of downstream classification and segmentation tasks. Our method has further reduced the effect that staining differences have on computational pathology, thereby improving the accuracy of histopathological image analysis to some extent.

7 October 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZHZhigang Hu
Zhigang Hu
GYGege Yang
Gege Yang
ZDZhe Du
Zhe Du
XHXiaodong Huang
Xiaodong Huang
PZPujing Zhang
Pujing Zhang
DLDechun Liu
Dechun Liu
In the field of computer vision, the application of hand-crafted as well as computer-learning-based methods in the field of image quality assessment has yielded remarkable results. However, in the field of no-reference image distortion, it is still challenging to accurately perceive and determine the quality of an image. To address the difficulties of Image Quality Assessment (IQA) in the field of authentic distorted images, we consider the use of the Swin Transformer (ST) to extract features. To enable the model to focus on both spatial and channel information of features, we design a plug-and-play Global Self-Attention Block (GSAB). At the same time, we introduce a Transformer block in the model to enhance the model’s ability to capture long-range dependencies. Finally, we derive the prediction of image quality scores through a Dual-Branching structure. Our method is experimented on four synthetic datasets as well as two authentic datasets, and the results of the experiments are weighted according to the size of the datasets, and the results show that our method outperforms all the current methods and works well in the Generalization ability test, which proves that our method has a good generalization ability. The code will be posted subsequently athttps://github.com/yanggege-new/NR-IQA-based-on-global-awareness.